PTSM: Pharmaceutical Technology Sourcing and Management, Oct 12, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Oct 12, 2010
Sourcing
Collaborative Innovation in Sourcing and Procurement
By Patricia Van Arnum
Gregg Brandyberry, CEO of Wildfire Commerce, senior advisor of AT Kearney procurement and analytic solutions, and former vice-president of procurement of global systems and operations for GlaxoSmithKline, discusses collaborative innovation in customer-supplier relations.
Outsourcing
R&D Mash-ups
By Jim Miller
Changing demands in drug development lead to new service combinations and models.
CSR and Sustainability Forum
World Leaders Map Strategy for Achieving Millennium Development Goals
By Patricia Van Arnum
World leaders gathered at the United Nations last month to review the progress and map out a strategy for achieving the Millennium Development Goals.
Roche Gains Top Spot in Sustainability Among Pharmaceutical Companies
By Patricia Van Arnum
An annual analysis rates the performance of pharmaceutical and biotechnology companies in corporate sustainability.
CSR and Sustainability Forum
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here